Lauren Santye, Assistant Editor

Baby boomer generation are five times more likely to be diagnosed with hepatitis C virus.

Biosimilar to rheumatoid arthritis and inflammatory bowel disease drug shows similar efficacy to brand name drug.

Top news of the day from across the health care landscape.

Adherence to oral PrEP combined with coordinated counseling found to improve HIV therapy.

Women with gestational diabetes found to breastfeed less often and for shorter duration.

Patients who relapse following a stem cell transplant for leukemia, lymphoma, or multiple myeloma may benefit from ipilimumab.

Adcetris is an antibody-drug conjugate that may improve treatment of cutaneous T cell lymphoma.

Once-daily dose prevented vaginal and oral HIV transmission in animal models.

Biosimilar to rheumatoid arthritis and inflammatory bowel disease drug shows similar efficacy to brand name drug.

Top news of the day from across the health care landscape.

COPD-related costs reduced from therapies that treat moderate-to-severe COPD.

Meaningful clinical activity found from PD-1 blockade treatment in metastatic prostate cancer patients resistant to androgen deprivation.

Perceived memory problems could be linked to stress rather that treatment in breast cancer survivors.

Debate continues surrounding cost versus cure in hepatitis C treatment.

Viral suppression may translate to safe sex among couple with an HIV positive individual.

People with pale skin, freckles, and red hair carry mutations comparable to an extra 21 years of sun exposure.

Researchers gain insight on genetic variants that influence the development of type 2 diabetes.

Fluorescence lifetime imaging identifies which breast cancer patients will benefit from specific treatments.

Top news of the day from across the health care landscape.

Funds from social media phenomenon leads to breakthrough discovery in amyotrophic lateral sclerosis (ALS).

Add-on therapy to interferon beta-1a is a potentially groundbreaking oral antibiotic combination.

Neratinib and the combination of veliparib plus carboplatin improves breast cancer outcomes.

Fixed oral drug for relapsed-remitted multiple sclerosis as an add-on to interferon beta-1a is a potentially groundbreaking antibiotic combination.

Top news from across the health care landscape.

Anti-PD-L1 immunotherapy with an MEK inhibitor may improve treatment of microsatellite-stable metastatic colorectal cancer.

Microscopic silk swimming device may improve treatment for variety of diseases.

Publically available value frameworks missing from many insurers' decision-making process.

CDC raises concerns about mother-to-child transmission of hepatitis C virus.

Ipilimumab combined with local peripheral treatments shows promise in malignant melanoma.

Metformin may help reduce rates of premature births and miscarriages.